30 Years of Pharma: Perspective in Numbers, Part 1

Healthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before.

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.

Collaboration aims to advance the development of treatments for multiple neurodegenerative conditions, including amyotrophic lateral sclerosis.

Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; and Andy Studna, associate editor, discussing industry trends in areas such as Chinese biotech, corporate branding, psychedelic medicines, and market access barriers.

Mills is working in leadership in two roles, one of which puts her on the forefront of the genomic medicine movement.

Marquez discusses the results of a recent survey about how elements of the industry are reacting to a post remote-work world.